Endoscopy News and Research

RSS

MEDNAX acquires Florida Atlantic Anesthesia

MEDNAX, Inc., today announced the acquisition of Florida Atlantic Anesthesia, Inc., a physician group practice that provides anesthesia services in Fort Lauderdale, Fla.

25 Jun 2012

Natural language processing programs can help measure colonoscopy quality

A new study shows that natural language processing programs can "read" dictated reports and provide information to allow measurement of colonoscopy quality in an inexpensive, automated and efficient manner.

23 Jun 2012

Fujifilm announces availability of Synapse Mobility 3.0

FUJIFILM Medical Systems U.S.A., Inc. announced the availability of Synapse Mobility 3.0, a new zero footprint application with improved features that enable access to Fujifilm's suite of Synapse products from hand-held mobile devices, as well as Macintosh- or Windows-based PCs.

8 Jun 2012

External LED light source for Endolume announced by Lighthouse Imaging

Lighthouse Imaging Corporation now offers the L700, an external LED light source, as a companion product to its Endolume endoscope system light tester. This inexpensive light source, when used in conjunction with Endolume, provides the necessary illumination to enable biomedical technicians, clinical engineers, and endoscope service technicians to quantitatively test the illumination characteristics of the endoscopic system.

31 May 2012

NYULMC opens new 327,000 square-foot Ambulatory Care Center

As part of its plan to expand access to a wide array of outpatient services, NYU Langone Medical Center has opened a new 327,000 square-foot Ambulatory Care Center (ACC) at 240 East 38th Street.

24 May 2012

Gattex may represent new treatment approach for short bowel syndrome

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing innovative therapeutics for rare gastrointestinal and endocrine disorders, today reported the presentation of data at the Digestive Disease Week (DDW) meeting held May 19-22 in San Diego.

22 May 2012

Studies of technological innovations presented at DDW annual meeting

Studies of technological innovations being presented for the first time at Digestive Disease Week- (DDW) showed increased accuracy coupled with decreased cost, time or invasiveness of gastrointestinal procedures. Use of a new high-definition colonoscope, for example, improved physician confidence in diagnosing small polyps, potentially reducing the amount of polyps sent for pathology analysis and the associated costs.

From Evident Corporation - Life Sciences 22 May 2012

New research reveals effective treatments for gastrointestinal conditions

New research being presented at Digestive Disease Week- (DDW) reveals effective treatments for a number of gastrointestinal conditions, which are often chronic and costly.

22 May 2012

Data from Janssen’s SIMPONI Phase 3 study on ulcerative colitis

New study findings presented today show that subcutaneous induction regimens of the anti-tumor necrosis factor (TNF)-alpha therapy SIMPONI (golimumab) induced clinical response in a majority of patients with moderately to severely active ulcerative colitis (UC) who had previously failed or were intolerant to conventional agents.

22 May 2012

CSA Medical unveils new truFreeze Spray Cryotherapy System

CSA Medical, Inc. unveiled the new truFreeze Spray Cryotherapy System this week at the Digestive Disease Week (DDW) 2012 Annual Meeting in San Diego.

21 May 2012

Cook Medical adds 25 gage needle to line of FNB histology portfolio

Cook Medical has added a 25 gage needle to its EchoTip ProCore line of fine needle biopsy (FNB) histology needles, which are designed for use in a procedure known as endoscopic ultrasound, or EUS. The EchoTip ProCore is a single-use, disposable needle for FNB intended for sampling of submucosal lesions, mediastinal masses, lymph nodes and intraperitoneal masses.

21 May 2012

Pernix Therapeutics introduces Omeclamox-Pak® for the treatment of H. pylori infection and duodenal ulcer disease

Pernix Therapeutics Holdings, Inc. (NYSE Amex: PTX), a specialty pharmaceutical company, today announced the introduction of Omeclamox-Pak®, a ten-day therapy of omeprazole delayed-release capsules (20 mg), clarithromycin tablets (500 mg) and amoxicillin capsules (500 mg) for the treatment of Helicobacter pylori (H. pylori) infection and duodenal ulcer disease (active or one-year history) to eradicate H. pylori in adult patients.

21 May 2012

Online instructional video improves patient compliance with colonoscopy

Patients who watch an online instructional video are more likely to keep their appointments and arrive prepared for a scheduled colonoscopy than those who do not, according to a study by gastroenterologists at the University of Chicago Medicine.

21 May 2012

Santarus to present UCERIS Phase III trial data on ulcerative colitis at DDW meeting

Santarus, Inc. today announced that safety and efficacy data from a Phase III, double-blind, multicenter, placebo-controlled 12 month extended use study with the investigational drug UCERIS (budesonide) 6 mg tablets will be featured in four poster presentations at the Digestive Disease Week (DDW) Meeting being held at the San Diego Convention Center on May 19 - 22, 2012.

19 May 2012

Clinical data from Boston Scientific endoscopy studies to be presented at DDW

Boston Scientific Corporation announces that seven abstracts and additional clinical data analyses will be presented at Digestive Disease Week (DDW), May 19 – 22 in San Diego.

19 May 2012

Accellent first quarter net sales increase 1.3% to $131.6 million

Accellent Inc., a wholly owned subsidiary of Accellent Holdings Corp., today announced results for its fiscal first quarter ended March 31, 2012.

15 May 2012

Inflammation might be an important factor in the progression from reﬂux to esophageal cancer

Inﬂammation might be an important factor in the progression from reﬂux to esophageal cancer, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association.

11 May 2012

Covidien to unveil new OneShot renal denervation system at EuroPCR congress

Covidien, a leading global provider of healthcare products, will unveil its new OneShot renal denervation system at the EuroPCR congress in Paris, France, on May 16, 2012. Adding to the Company's broad and growing vascular therapies portfolio, the OneShot system is designed to treat patients with hypertension who are not responsive to traditional medical therapy.

8 May 2012

Accellent to sell Pittsburgh facility to Perryman

Accellent Inc., a wholly-owned subsidiary of Accellent Holdings Corp., has entered into an agreement to sell its facility located just outside of Pittsburgh in Houston, Pennsylvania to The Perryman Company, also headquartered in Houston, Pennsylvania. Substantially all of the Facility's employees will become employees of Perryman effective upon completion of the sale, which is expected to be completed during the second quarter of 2012.

5 May 2012

The skills of VA nurses under examination after patient deaths

Earlier this month, a broader review by the VA inspector general of 29 VA facilities found only half had adequately documented that their nurses had the needed skills. ... The April 20 IG report also noted that previous inspections had found nurse competency issues in "dialysis, mental health, long-term care, spinal cord injury, endoscopy procedure areas, the operating room and the cardiac catheterization laboratory and with reusable medical equipment.

2 May 2012